Inactivation of MSMEG_0412 gene drastically affects surface related properties of Mycobacterium smegmatis
- 1.1k Downloads
The outermost layer of mycobacterial cell wall is rich in lipids and glycolipids, surface molecules which differ among species. Mycobacterium smegmatis, an attractive model for the study of both pathogenic and non-pathogenic mycobacteria, presents glycopeptidolipids (GPLs). All the genes necessary for the biosynthesis of such molecules are clustered in a single region of 65 kb and among them, the msmeg_0412 gene has not been characterized yet. Here we report the isolation and subsequent analysis of a MSMEG_0412 null mutant strain.
The inactivation of the msmeg_0412 gene had a drastic impact on bacterial surface properties which resulted in the lack of sliding motility, altered biofilm formation and enhanced drug susceptibility. The GPLs analysis showed that the observed mutant phenotype was due to GPLs deficiencies on the mycobacterial cell wall. In addition, we report that the expression of the gene is enhanced in the presence of lipidic substrates and that the encoded protein has a membrane localization.
msmeg_0412 plays a crucial role for GPLs production and translocation on M. smegmatis surface. Its deletion alters the surface properties and the antibiotic permeability of the mycobacterial cell barrier.
KeywordsMycobacterium smegmatis msmeg_0412 GPLs Lipolytic Cell wall Biofilm
Electrospray Ionization Mass Spectometer
Thin Layer chromatography
Mycobacterial cell wall is a unique well organized barrier which confers low permeability to different chemical agents and common antibiotics . The envelope is waxy, hydrophobic, and thicker compared to that of other bacteria and is organized in two compartments, the inner layer, covalently linked to the plasma membrane and formed by peptidoglycan, arabinogalactan and mycolic acid, and, the outer layer, which is essentially formed by glycolipids and proteins [2, 3]. Glycopeptidolipids (GPLs) are the major surface exposed molecules found in various mycobacterial species including non-pathogenic (e.g M. smegmatis) and non–tuberculous pathogenic mycobacteria (e.g. M. avium, M. intracellulare, M. abscessus) [4, 5]. GPLs have a common fatty acyl-tetrapeptide core which is glycosylated with 6-deoxy-l-talose and variable O-methyl-l-rhamnose residues [6, 7, 8]. This is known as non-serovar-specific GPL (nsGPLs) and represents the main product of M. smegmatis GPLs. In M. avium GPLs present a more complicated structure in which an additional rhamnose and oligosaccharide residues are added to 6-deoxy-l-talose, resulting in serovar-specific GPLs [7, 9, 10]. These molecules, which may represent more than 70 % of total surface lipids , are required for cell aggregation, sliding motility and biofilm formation [12, 13, 14, 15]. Moreover several studies reported that slight modifications of the GPLs structure are able to affect the mycobacterial ability to stimulate the host immune response, suggesting a role as antigenic molecules [16, 17, 18, 19].
The fast growing M. smegmatis is frequently used as a model organism to study the molecular and physiological mechanisms used by slow-growing pathogenic mycobacteria. The M. smegmatis GPLs biosynthetic locus has been previously characterized either experimentally or by in silico prediction [20, 21, 22, 23]. Most genes of the M. smegmatis GPL locus are conserved in two clinically significant mycobacterial species such as M. abscessus and M. avium subsp. paratuberculosis [5, 24].
Among them, the gene msmeg_0412 is still uncharacterized and its product shares 66 % and 67 % identity with the predicted protein MAB_0402, and MAP2244 from M. abscessus and M. avium subsp. paratuberculosis, respectively. Interestingly, M. tuberculosis, a mycobacterium which does not produce GPLs on the cell wall, presents Rv1184c which shares 45 % identity with MSMEG_0412. Rv1184c has been recently characterized as the Acyltransferase Chp2, essential for the final biosynthetic steps of polyacyltrehalose (PAT), a pentaacylated, trehalose-based glycolipids only found on the surface of pathogenic mycobacteria [25, 26].
In this study we show that the inactivation of msmeg_0412 gene alters the lipid profile surface of M. smegmatis and enhances the bacterial susceptibility to antibiotics. In addition, we report that msmeg_0412 gene expression is enhanced in the presence of lipidic substrates and that the encoded protein localizes on the cell wall. Taken together, our results indicate that MSMEG_0412 is an important player in the complex GPLs biosynthetic process in M. smegmatis and allow speculating that MSMEG_0412 is translocated to the cell wall where it contributes to GPLs synthesis.
Deletion of the msmeg_0412 gene alters M. smegmatis surface properties, enhances suscepitibility to antibiotics and affects GPLs synthesis
To confirm that these phenotypes were due to msmeg_0412 gene inactivation, we performed a complementation analysis. A wild type allele of the msmeg_0412 gene was PCR-amplified, cloned into pMV10-25 vector  without the gfp gene (methods), and transformed into strain GM1, yielding strain GM2. As shown in Fig. 2 all phenotypes of strain GM1 were rescued in strain GM2, that appeared identical to the wild type strain.
The drastic impact of msmeg_0412 deletion on M. smegmatis surface properties was also evidenced by a slower growth rate in liquid media with a generation time of the mutant of 4.5 h compared to 3 h of the wt strain (see Additional file 1: Figure S1) and by the enhanced susceptibility to antimicrobials. As shown in Fig. 2d, when streaked on LB agar medium containing Rifampicin at a sub-MIC concentration (10 μg/ml) , the GM1 strain was unable to grow compared to the wild type and complemented strains. The same result was obtained using Erythromycin as antibiotic (13 μg/ml) . Since both antibiotics have cytosolic targets, it is possible to hypothesize that the mutation induces changes in the cell wall permeability that lead to an increase in antibiotics penetration.
The msmeg_0412 gene expression is induced by lipid substrates
Based on this result we decided to evaluate the effect of tween 80 on the growth of the mutant strain. To this purpose wt, GM1 and GM2 strains were grown in minimal medium containing 0.2 % (w/v) glucose or 1%t ween 80 as the only carbon source. The result (see Additional file 3: Figure S3) clearly indicated that the mutant was unable to grow in presence of tween 80. Although this result, together with the bioinformatic analysis, allows speculating a lipolytic function for MSMEG_0412, a detailed biochemical characterization is needed to decipher its function.
The MSMEG_0412 protein is localized on the cell wall
Mycobacteria comprise bacilli with a specialized cell wall divided in two compartments: the inner- and the outer- layer. The latter is rich in lipids and glycolipids which differ among species. M. smegmatis shares a richness in glycopeptidolipids (GPLs) with pathogenic non tubercle mycobacteria, such as M. abscessus and M. avium.
Msmeg_0412, a gene located in the GPLs biosynthetic locus, is highly conserved among mycobacteria, and its product shares 45 % identity with Rv1184c from the human pathogen M. tuberculosis. The gene encodes a protein which primary structure has features of proteins annotated as putative lipases or esterases.
Lipase/esterase-like enzymes belong to a family of proteins involved in lipid metabolism, which play a crucial role during mycobacterial infection and persistence inside the host [30, 32]. In fact, it has been reported that such enzymes contribute to the destruction of the host tissues thereby supplying nutrients to the pathogens [33, 34]. Therefore, a better understanding of these proteins will surely help in developing new strategies against mycobacterial infections.
Earlier reports have clearly indicated that the loss of GPLs on M. smegmatis surface induce an increased cell wall hydrophobicity [14, 15, 23] which results in the alteration of surface properties such as a change of colony morphotype (from smooth to rough), an altered biofilm formation at liquid/air interface, and the inability to slide on soft agar plates. Here we report the construction and analysis of a M. smegmatis strain carrying a null mutation in msmeg_0412 gene.
Our results show that MSMEG_0412 is required for the correct processing of the GPLs on mycobacterial surface and that its deletion induced a surface perturbation. Furthermore, in line with the bioinformatic predictions, the msmeg_0412 gene expression is enhanced in the presence of lipid substrates, and the protein encoded localizes on the cell wall. Taken together our results allow to speculate that once synthesized, MSMEG_0412 is translocated to the cell wall, where plays a crucial role for the correct GPLs processing and translocation on M. smegmatis surface. A further biochemical approach is needed to better clarify other aspects of the function and the localization of this important protein.
The analysis of msmeg_0412 mutant highlighted that this gene is important for Mycobacterium smegmatis surface organization and resulted in different important phenotypes, as lack of sliding motility, altered biofilm formation and enhanced drug susceptibility. The analysis of Glycopeptidolipids (GPLs) component of bacterial surface showed that the msmeg_0412 mutant was strongly impaired for GPLs presence in the mycobacterial cell wall. In addition, based on in-silico predictions, we report that the expression of the gene is enhanced by the presence of lipidic substrates and that the encoded protein has a membrane localization.
Finally, generation time of the mutant was shorter than the one of the wild type strain.
Mutations affecting the organization of the cell wall have often pleiotropic effects. This is the first experimental evidence for an involvement of msmeg_0412 gene in the synthesis of the GPLs.
Taken together, the results presented in this manuscript offer the possibility to consider MSMEG_0412 as a new target to impair the mycobacterial growth and to increase drug susceptibility.
Bacterial strains, media and growth conditions
The recombinant strain GM1, carrying a msmeg_0412 gene deletion was engineered using the p2NIL/pGOAL19-based flexible cassette method as previously reported .
M. smegmatis mc2155 and derivatives were grown in 7H9 medium (Difco) containing 2 % glycerol and 0.05 % tween 80 (Applichem) or in M9 containing 1 mM Mg2SO4 and 0.2 % glucose. Where indicated, glucose was replaced by 1 % glycerol-tributyrate (tributyrin) or 1 % tween 80.
E. coli strains were grown in LB medium. When required, antibiotics were added to the medium at the following final concentrations: ampicillin 100 μg/ml, hygromycin at 200 μg/ml for E. coli and 50 μg/ml for M. smegmatis mc2155, respectively.
For the antimicrobial susceptibility test, Erythromycin and Rifampicin were added to LB agar medium at the following final concentrations: 13 μg/ml and 10 μg/ml respectively.
For the Microscopy analysis, samples were observed using an Olympus BX51 fluorescence microscope using a FITC filter. The Images were captured using an Olympus DP70 digital camera and processed. Standard acquisition times were 200 ms.
A multiple sequence alignment was carried out using PRALINE (http://www.ibi.vu.nl/programs/pralinewww) as program. MSMEG_0412 aminoacid sequence was used as query against the earlier identified M. tuberculosis proteins  showing the conserved pentapetide sequence motif (GXGXG) and the conserved Ser, Asp and His catalytic triad characteristic of lipase/esterase activities.
The signal peptide server, (http://www.cbs.dtu.dk/services/SignalP), was used to predict the presence and location of the signal peptide cleavage site inside MSMEG_0412.
Sliding motility assay
Congo red assays
Plasmid and chromosomal DNA preparation, restriction digestion, ligation, bacterial transformation and agarose gel electrophoresis were performed as described .
Sequence (5′ - 3′)a
Position of Annealingb
Plasmid pGM6, used for complementation analysis, was constructed as follow: the wild type msmeg_0412 gene from M. smegmatis wild type strain was PCR amplified with Pfu Turbo high Fidelity DNA polymerase (Stratagene) using chromosomal DNA as template and the oligo 0412-Fw and 0412-Rv (Table 1) as primers. The last ones contained the engineered NheI and BamHI restriction sites respectively.
The PCR product of expected size was purified with a PCR Purification Kit (Qiagen), digested with NheI and BamHI restriction enzymes and cloned under the hsp60 promoter into the shuttle vector pMV10-25 , previously digested with the same enzyme pairs which allowed the excision of the gfp encoding gene. The resulting plasmid was controlled by sequencing and then used to transform GM1 cells, giving the strain GM2.
Plasmid pGM7 and pGM8 containing the entire version or the truncated version of the msmeg_0412 gene fused to the gfp reporter gene, respectively, were constructed as follow: the msmeg_0412 gene except the stop codon was PCR amplified with Pfu Turbo high Fidelity DNA polymerase (Stratagene) using chromosomal DNA as template and priming the reaction with two different couples of primers: 0412-Fw and 0412-gfpRv or 0412-spFw and 0412-gfpRv (Table 1). The first couple of primers has allowed to amplify the entire copy of the gene, the other combination of primers has allowed to amplify the gene that misses of 84 bp, encoding a putative N-terminal signal peptide. All primers contained a 5’ engineered NheI restriction site. The PCR products of expected sizes were purified with the PCR purification Kit (Qiagen) digested with the NheI restriction enzyme and cloned in the plasmid pMV10-25 , under the control of hsp60 promoter and in frame with GFP coding gene using the NheI restriction site located at 5’ end of gfp.
The resulting plasmids were controlled by sequencing and then used to transform M. smegmatis wild type cell, giving the strains GM7 and GM8 respectively.
Isolation of Δmsmeg_0412 mutant strain
The msmeg_0412 null mutant strain, named GM1, was obtained by using the allelic replacement system reported previously .
The pGM5 suicide vector was used to transform cells of M. smegmatis mc2155 strain and transformants were selected on LB agar plates supplemented with hygromicin (200 mg/ml), kanamycin (25 mg/ml) and X-Gal (50 mg/ml). Blue colonies were restreaked onto LB agar plates; a loopful of cells was then resuspended in LB broth, serially diluted and plated on LB agar containing 2 % sucrose (Suc) and X-gal. White KanS, HygS and SucR colonies were isolated and identified by PCR analysis. One KanS, HygS and SucR colony with a deleted msmeg_0412 gene was identified as GM1 strain.
Total RNA was extracted by using the RNeasy Mini Kit (QIAGEN) according to manufacturer’s protocol. RNAs were resuspended in 100 ml of RNAse-free water and treated with DNAse I (Fermentas, 1U/ml) for 30 minutes at 37 °C. The quality of RNA samples were estimated using the RNA nanochip on the Thermoscientific Nanodrop 1000. The concentration of RNA was determined by measuring the absorbance at 260 nm.
Real Time PCR analysis
cDNA was synthesized by using PrimeScript Enzyme mix (Takara) and random hexamers as primers. Primers 0412-S and 0412-A (Table 1), and those for the normalizing gene 16S, 16S-fw (5′-GGCGAACGGGTGAGTAACA-3′) and 16S-Rv (5′-GCCCTGCACTTTGGGATAAG-3′), were designed with ABI PRISM Primer Express software (PE Applied Biosystems). Real-Time PCR was performed by using SYBR green RT-PCR (Takara). Reactions were performed as previously described . Values reported here were the average of at least three independent experiments and were expressed as the mean ± SEM (Standard Error of the Mean). The fluorescence signal due to SYBR Green intercalation was monitored to quantify the double-stranded DNA product formed in each PCR cycle. Statistical significance was determined by Student’s unpaired t-test and the significance levels were reported in the text.
Extraction and analysis of mycobacterial lipids
Total lipids were extracted from whole cells as previously reported . In brief, cells from wt, mutant and complemented strains were grown in LB medium until stationary phase (OD600: 2.5), harvested 10 minutes at 7000 rpm and resuspended in PBS, pH 7.4. Lipids were extracted with CHCl3:CH3OH (1:2 v/v) for 24 hours, separately dried under vacuum and partitioned between water and chloroform (1:1 v/v).
The organic phases were further washed with distilled water and evaporated to dryness. For analytical thin-layer chromatography (TLC), the crude residues (1.0 mg) were dissolved in CHCl3:CH3OH (0.75 mL, 9:1 v/v), spotted on silica gel 60-precoated plates (0.25-mm thickness, Merck) and eluted with CHCl3:CH3OH (9:1 v/v). Sugar-containing compounds were visualized by spraying TLC plates with a chromosulfuric acid staining solution and charring them at 200 °C for 2 min. The GPLs were detected as brownish-red spots. Conversely, the lipid content in the three strains was detected by extracting the crudes with hexane (0.3 mL). The resulting solutions were spotted on TLC plates which were eluted in toluene:acetone (99:1 v/v). In this case, lipids were visualized by spraying the plates with a cerium molybdate staining solution and charring them at 200 °C for 2 min. The lipids were detected as dark blue spots.
ESI-MS analysis of the organic extracts was performed using a Shimadzu LC-MS-2010EV system with ESI interface, Q-array-octapole-quadrupole mass analyser and a Shimadzu LC-MS solution Workstation software for data processing. The optimized MS parameters were selected as follows: CDL (curved desolvation line) temperature 250 °C; heat block temperature 250 °C; probe temperature 250 °C; detector gain 1.6 kV; probe voltage +4.5 kV; CDL voltage -15 V. Nitrogen served as nebulizing (flow rate: 1.5 L/min) and drying gas (flow rate: 15 L/min). Each sample (0.5 mg) was dissolved in 1 mL of acetonitrile (ACN)/0.1 % trifluoroacetic acid (TFA); 2 μL aliquots of the resulting solutions were injected using ACN/0.1 % TFA as solvent (flow rate: 0.2 mL/min). MS spectra were acquired in positive ion mode.
We would like to acknowledge Prof. Ezio Ricca for critical reading of the manuscript.
This work was financially supported by the Department of Biology of the University of Naples “Federico II”.
Availability of data and material
The data supporting the conclusion of this work are included within the article.
AC conceived the study; AZ, AM, and AC performed mutant isolation, strains construction and phenotypic analysis, Real-Time PCR experiments and Fluorescence microscopy analysis; DD and AL carried out lipid extraction and analysis; AZ, MV and AC analyzed data and wrote the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
This work did not involve human subjects, human material, or human data and therefore does not require ethical approval.
- 11.Billman-Jacobe H. Glycopeptidolipid synthesis in Mycobacteria. Curr Sci. 2004;86:11–114.Google Scholar
- 14.Etienne G, Villeneuve C, Billman-Jacobe H, Astarie-Dequeker C, Dupont MA, Daffè M. The impact of the absence of glycopeptidolipids on the ultrastructure, cell surface and cell wall properties, and phagocytosis of Mycobacterium smegmatis. Microbiology. 2002;148:3089–100.Google Scholar
- 16.Villeneuve C, Etienne G, Abadie V, Montrozier H, Bordier C, Laval F, Daffè M, et al. Surface-exposed glycopeptidolipids of Mycobacterium smegmatis specifically inhibit the phagocytosis of mycobacteria by human macrophages. Identification of a novel family of glycopeptidolipids. JBC. 2003;278:51291–300.CrossRefGoogle Scholar
- 19.Nessar R, Reyrat J, Davidson LB, Byrd TF. Deletion of the mmpL4b gene in the Mycobacterium abscessus glycopeptidolipid biosynthetic pathway results in loss of surface colonization capability, but enhanced ability to replicate in human macrophages and stimulate their innate immune response. Microbiology. 2011;157:1187–95.CrossRefPubMedGoogle Scholar
- 29.Lu T, Zhao X, Li X, Hansen G, Blondeau J, Drlica K. Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus. J Antimicrobial Chemother. 2003;52:61–4.CrossRefGoogle Scholar
- 36.Sambrook J, Fitsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Press; 1989.Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.